Pulmonary Embolism Clinical Trial
Official title:
Estimation of the Risk of Pulmonary Embolism and Venous Thromboembolism in Pregnancy After in Vitro Fertilization.
Occurrence of venous thromboembolism during in Vitro Fertilization (IVF) pregnancies has
been reported in numerous case reports and in two small consecutive series. The incidence of
venous thromboembolism (VTE) after IVF has been claimed to be comparable to the incidence of
VTE during normal pregnancy. No information exists concerning pulmonary embolism (PE).
The aim is to estimate and compare the risk of both PE and VTE during the the different
phases of pregnancy after IVF to that in age and period matched control women. The
investigators will use the Swedish National Health Registers to estimate the risk.
Background: Occurrence of venous thromboembolism (VTE) during IVF pregnancies has been
reported in numerous case reports and in two small consecutive series. The incidence of VTE
after IVF has been claimed to be comparable to the incidence of VTE during normal pregnancy.
No information exists concerning pulmonary embolism (PE).
Aim: The aim is to estimate and compare the risk of both PE and VTE during the trimesters of
pregnancy after IVF to that in age and period matched control women.
Design and methods: A cross-sectional study using linkage of Swedish population and health
registers. The Swedish National Patient Register encompasses inpatients and outpatients.
Inpatient data in Sweden is available nationwide since 1987. Outpatient diagnoses from
hospitals started to be collected in 1997. Data in the Patient Register will be linked to
the Swedish Medical Birth Register (MBR) at the National Board of Health and Welfare through
the unique personal identity number assigned to all Swedish residents, Exposed women:
Mothers who had given birth to a child as a result of IVF will be retrieved from the Swedish
IVF Register at the National Board of Health and Welfare. The Swedish IVF Register is now a
part of the Swedish Medical Birth Register (MBR) at the National Board of Health and Welfare
and includes information on IVF pregnancies since 1982.
We will restrict the retrieval to mothers of a child born as from 1990 until 2008 and who
had their first child born after assisted reproduction by IVF.
Unexposed women: Each IVF woman will be matched with 5 unexposed women from the MBR by
calendar year of delivery and maternal age.
Information will be retrieved on country of birth, pre-pregnancy body mass index, family
situation, cigarette smoking habits, number of older siblings, singleton/multiple births,
and estimated length of gestation from the MBR register. Dates of the trimesters is
calculated from the length of gestation. Women´s education is found in the Register of
Education, Statistics Sweden, by linkage through the personal identity number.
Diagnoses of VTE including PE will be found by linkage to the Swedish Patient Register of
the National Board of Health and Welfare. This register comprises date of admission and
discharge, and main diagnosis with up to seven contributing diagnoses. Diagnoses are
recorded according to the International Classification of Diagnoses (ICD), ninth version
prior to 1996 and the tenth version from 1997. Codes used were 415B, 451B, 452, 453C-D,
453W, 453X, 673C, 671D-E, 671F in ICD9 and I260, I269, I801- 3, I808-9, I822-3, I828-9,
O223, O225, O871, O873, O879, O882 in ICD10.
The study is approved by the Research Ethics Committee of Karolinska Institutet, Stockholm,
Sweden (Dnr 2010/267-31/4).
;
Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05050617 -
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
|
||
Terminated |
NCT04558125 -
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
|
Phase 4 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Completed |
NCT03915925 -
Short-term Clinical Deterioration After Acute Pulmonary Embolism
|
||
Completed |
NCT02502396 -
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
|
||
Recruiting |
NCT05171075 -
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
|
Phase 3 | |
Completed |
NCT04454554 -
Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
|
||
Completed |
NCT03173066 -
Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
|
Phase 1 | |
Terminated |
NCT03002467 -
Impact Analysis of Prognostic Stratification for Pulmonary Embolism
|
N/A | |
Completed |
NCT02611115 -
Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography.
|
N/A | |
Completed |
NCT02334007 -
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT01975090 -
The SENTRY Clinical Study
|
N/A | |
Not yet recruiting |
NCT01357941 -
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
|
N/A | |
Completed |
NCT01326507 -
Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism
|
N/A | |
Completed |
NCT00780767 -
Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism
|
Phase 2 | |
Completed |
NCT00773448 -
Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism
|
N/A | |
Completed |
NCT00771303 -
Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
|
||
Completed |
NCT02476526 -
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00720915 -
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
|
N/A | |
Completed |
NCT00244725 -
Odiparcil For The Prevention Of Venous Thromboembolism
|
Phase 2 |